Elevated concentration of microvesicles isolated from peripheral blood in breast cancer patients

Archives of Medical Research

Volumn 44, Issue 3, 2013, Pages 208-214

  Galindo Hernandez, Octavio ^a   Villegas Comonfort, Socrates ^a   Candanedo, Fernando ^a   González Vázquez, María Cristina ^a   Chavez Ocaña, Sonia ^b   Jimenez Villanueva, Xicotencatl ^b   Sierra Martinez, Monica ^b   Salazar, Eduardo Perez ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

Breast cancer; EGFR; FAK; Microvesicles

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FOCAL ADHESION KINASE;

ADULT; AGED; ARTICLE; BLOOD; BLOOD SAMPLING; BREAST CANCER; CANCER PATIENT; CANCER SIZE; CANCER STAGING; CENTRIFUGATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXOSOME; HUMAN; MICROVESICLE; PROTEIN ANALYSIS; THROMBOCYTE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PLATELETS; BREAST NEOPLASMS; CELL MEMBRANE; CYTOPLASMIC VESICLES; FEMALE; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MIDDLE AGED; PLASMA; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84876867466     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2013.03.002     Document Type: Article

References (42)

1. Jemal A., Bray F., Center M.M., et al. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Gerber M. Background review paper on total fat, fatty acid intake and cancers. Ann Nutr Metab 2009, 55:140-161.
3. WCRF/AICR World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective 2007, AICR, Washington, DC.
4. Muralidharan-Chari V., Clancy J.W., Sedgwick A., et al. Microvesicles: mediators of extracellular communication during cancer progression. J Cell Sci 2010, 123:1603-1611.
5. Inal J.M., Ansa-Addo E.A., Stratton D., et al. Microvesicles in health and disease. Arch Immunol Ther Exp (Warsz) 2012, 60:107-121.
6. Horstman L.L., Ahn Y.S. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999, 30:111-142.
7. Hagerstrand H., Isomaa B. Lipid and protein composition of exovesicles released from human erythrocytes following treatment with amphiphiles. Biochim Biophys Acta 1994, 1190:409-415.
8. Koumangoye R.B., Sakwe A.M., Goodwin J.S., et al. Detachment of breast tumor cells induces rapid secretion of exosomes which subsequently mediate cellular adhesion and spreading. PLoS One 2011, 6:e24234.
9. Sustar V., Bedina-Zavec A., Stukelj R., et al. Nanoparticles isolated from blood: a reflection of vesiculability of blood cells during the isolation process. Int J Nanomed 2011, 6:2737-2748.
10. Thery C., Zitvogel L., Amigorena S. Exosomes: composition, biogenesis and function. Nat Rev Immunol 2002, 2:569-579.
11. Jy W., Horstman L.L., Jimenez J.J., et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004, 2:1842-1851.
12. Diamant M., Tushuizen M.E., Sturk A., et al. Cellular microparticles: new players in the field of vascular disease?. Eur J Clin Invest 2004, 34:392-401.
13. Distler J.H., Pisetsky D.S., Huber L.C., et al. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum 2005, 52:3337-3348.
14. Lee T.H., D'Asti E., Magnus N., et al. Microvesicles as mediators of intercellular communication in cancer-the emerging science of cellular 'debris'. Semin Immunopathol 2011, 33:455-467.
15. Ratajczak J., Wysoczynski M., Hayek F., et al. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20:1487-1495.
16. Valenti R., Huber V., Iero M., et al. Tumor-released microvesicles as vehicles of immunosuppression. Cancer Res 2007, 67:2912-2915.
17. Kosaka N., Iguchi H., Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci 2010, 101:2087-2092.
18. Baran J., Baj-Krzyworzeka M., Weglarczyk K., et al. Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol Immunother 2010, 59:841-850.
19. Montes M., Jaensson E.A., Orozco A.F., et al. A general method for bead-enhanced quantitation by flow cytometry. J Immunol Methods 2006, 317:45-55.
20. Orozco A.F., Lewis D.E. Flow cytometric analysis of circulating microparticles in plasma. Cytometry A 2010, 77:502-514.
21. Antonyak M.A., Li B., Boroughs L.K., et al. Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells. Proc Natl Acad Sci USA 2011, 108:4852-4857.
22. Diamant M., Nieuwland R., Pablo R.F., et al. Elevated numbers of tissue-factor exposing microparticles correlate with components of the metabolic syndrome in uncomplicated type 2 diabetes mellitus. Circulation 2002, 106:2442-2447.
23. Kim H.K., Song K.S., Park Y.S., et al. Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur J Cancer 2003, 39:184-191.
24. D'Souza-Schorey C., Clancy J.W. Tumor-derived microvesicles: shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012, 26:1287-1299.
25. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009, 9:239-252.
26. Schlaepfer D.D., Hauck C.R., Sieg D.J. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999, 71:435-478.
27. Navarro-Tito N., Robledo T., Salazar E.P. Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells. Exp Cell Res 2008, 314:3340-3355.
28. Parsons J.T. Focal adhesion kinase: the first ten years. J Cell Sci 2003, 116:1409-1416.
29. Schaller M.D. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta 2001, 1540:1-21.
30. Zhao J., Guan J.L. Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 2009, 28:35-49.
31. Agochiya M., Brunton V.G., Owens D.W., et al. Increased dosage and amplification of the focal adhesion kinase gene in human cancer cells. Oncogene 1999, 18:5646-5653.
32. Weiner T.M., Liu E.T., Craven R.J., et al. Expression of focal adhesion kinase gene and invasive cancer. Lancet 1993, 342:1024-1025.
33. Cance W.G., Harris J.E., Iacocca M.V., et al. Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res 2000, 6:2417-2423.
34. Nicholson R.I., Gee J.M., Harper M.E. EGFR and cancer prognosis. Eur J Cancer 2001, 37(suppl 4):S9-S15.
35. Arteaga C.L. Epidermal growth factor receptor dependence in human tumors: more than just expression?. Oncologist 2002, 7(suppl 4):S31-S39.
36. Bazley L.A., Gullick W.J. The epidermal growth factor receptor family. Endocr Relat Cancer 2005, 12(suppl 1):S17-S27.
37. Dawson S.J., Provenzano E., Caldas C. Triple negative breast cancers: clinical and prognostic implications. Eur J Cancer 2009, 45(suppl 1):S27-S40.
38. Burness M.L., Grushko T.A., Olopade O.I. Epidermal growth factor receptor in triple-negative and basal-like breast cancer: promising clinical target or only a marker?. Cancer J 2010, 16:23-32.
39. Sebastian S., Settleman J., Reshkin S.J., et al. The complexity of targeting EGFR signalling in cancer: from expression to turnover. Biochim Biophys Acta 2006, 1766:120-139.
40. Al-Nedawi K., Meehan B., Kerbel R.S., et al. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA 2009, 106:3794-3799.
41. Al-Nedawi K., Meehan B., Micallef J., et al. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells. Nat Cell Biol 2008, 10:619-624.
42. Skog J., Wurdinger T., van Rijn S., et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008, 10:1470-1476.